© The Rockefeller University Press, 0022-1007/1998/5/1403/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 9, May 4, 1998 1403-1415
Exogenously Provided Peptides of a Self-antigen Can Be Processed into Forms that Are Recognized by Self–T Cells
Avlin K. Barlow,
Xin He, and
Charles Janeway, Jr.
Section of Immunobiology, Yale University School of Medicine, and Howard Hughes Medical Institute, New Haven, Connecticut 06510
Major histocompatibility complex (MHC) class II molecules can present peptides derived from two different sources. The predominant source of peptide in uninfected antigen presenting cells (APCs) is from self-proteins that are synthesized within the cell and traffic through the MHC class II compartment. The other source of antigen is endocytosed proteins, which includes both self- and foreign proteins. Foreign protein antigens generate adaptive immune responses, whereas self-peptides stabilize the MHC class II heterodimer on the cell surface, allowing positive and negative selection of thymocytes. Therefore, self-antigens play an important normal role in shaping the T cell receptor repertoire as well as a pathological role in autoimmunity. To determine whether processing and presentation of self-antigens by MHC class II molecules differs depending on whether the antigen is supplied through synthesis within the cell or by endocytosis, we used a T cell clone against an E
peptide presented by I-Ab to show that processing through these two routes can differ. We also show that mice can be tolerant to the epitope formed through the endogenous route, but responsive to the epitope that can be formed through endocytosis. This suggests that negative selection occurs primarily against antigens that are synthesized within the APC, and that endocytosed self-antigens could serve as autoantigens. Finally, we also demonstrate that lipopolysaccharide-activated B cells are defective for uptake, processing, and presentation of this self-antigen, and that this correlates with the increased expression of the costimulatory molecules B7.1 and B7.2. This may provide a model for studying the onset of an autoimmune response.
Address correspondence to Charles A. Janeway, Jr., Section of Immunology, Yale University School of Medicine, 310 Cedar St., LH416, Box 208011, New Haven, CT 06520. Phone: 203-785-2793; Fax: 203-737-1765; E-mail: charles.janeway{at}yale.edu
A.K. Barlow's present address is Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461.
2 Viret, C., H. Ramaswamy, D.B. Sant'Angelo, and C.A. Janeway, Jr., manuscript submitted for publication.
Abbreviations used: CIIV, class II loading vesicle; Ii, invariant chain; MIIC, MHC class II compartment.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Dani, A., Chaudhry, A., Mukherjee, P., Rajagopal, D., Bhatia, S., George, A., Bal, V., Rath, S., Mayor, S.
(2004). The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J. Cell Sci.
117: 4219-4230
[Abstract]
[Full Text]
-
Lovitch, S. B., Walters, J. J., Gross, M. L., Unanue, E. R.
(2003). APCs Present A{beta}k-Derived Peptides That Are Autoantigenic to Type B T Cells. J. Immunol.
170: 4155-4160
[Abstract]
[Full Text]
-
Chernysheva, A. D., Kirou, K. A., Crow, M. K.
(2002). T Cell Proliferation Induced by Autologous Non-T Cells Is a Response to Apoptotic Cells Processed by Dendritic Cells. J. Immunol.
169: 1241-1250
[Abstract]
[Full Text]
-
Kawahata, K., Misaki, Y., Yamauchi, M., Tsunekawa, S., Setoguchi, K., Miyazaki, J.-i., Yamamoto, K.
(2002). Peripheral Tolerance to a Nuclear Autoantigen: Dendritic Cells Expressing a Nuclear Autoantigen Lead to Persistent Anergic State of CD4+ Autoreactive T Cells After Proliferation. J. Immunol.
168: 1103-1112
[Abstract]
[Full Text]
-
Mukherjee, P., Dani, A., Bhatia, S., Singh, N., Rudensky, A. Y., George, A., Bal, V., Mayor, S., Rath, S.
(2001). Efficient Presentation of Both Cytosolic and Endogenous Transmembrane Protein Antigens on MHC Class II Is Dependent on Cytoplasmic Proteolysis. J. Immunol.
167: 2632-2641
[Abstract]
[Full Text]
-
Haque, M. A., Hawes, J. W., Blum, J. S.
(2001). Cysteinylation of MHC Class II Ligands: Peptide Endocytosis and Reduction Within APC Influences T Cell Recognition. J. Immunol.
166: 4543-4551
[Abstract]
[Full Text]
-
Vincent-Schneider, H, Thery, C, Mazzeo, D, Tenza, D, Raposo, G, Bonnerot, C
(2001). Secretory granules of mast cells accumulate mature and immature MHC class II molecules. J. Cell Sci.
114: 323-334
[Abstract]
-
Paul, A. G. A., van Kooten, P. J. S., van Eden, W., van der Zee, R.
(2000). Highly Autoproliferative T Cells Specific for 60-kDa Heat Shock Protein Produce IL-4/IL-10 and IFN-{gamma} and Are Protective in Adjuvant Arthritis. J. Immunol.
165: 7270-7277
[Abstract]
[Full Text]
-
Viret, C., He, X., Janeway, C. A. Jr.
(2000). On the Self-Referential Nature of Naive MHC Class II-Restricted T Cells. J. Immunol.
165: 6183-6192
[Abstract]
[Full Text]
-
Chaturvedi, P., Agrawal, B., Zechel, M., Lee-Chan, E., Singh, B.
(2000). A Self MHC Class II {beta}-Chain Peptide Prevents Diabetes in Nonobese Diabetic Mice. J. Immunol.
164: 6610-6620
[Abstract]
[Full Text]
-
Schnell, S., Young, J. W., Houghton, A. N., Sadelain, M.
(2000). Retrovirally Transduced Mouse Dendritic Cells Require CD4+ T Cell Help to Elicit Antitumor Immunity: Implications for the Clinical Use of Dendritic Cells. J. Immunol.
164: 1243-1250
[Abstract]
[Full Text]
-
Jhaver, K. G., Chandler, P., Simpson, E., Mellor, A. L.
(1999). Thymocyte Antigens Do Not Induce Tolerance in the CD4+ T Cell Compartment. J. Immunol.
163: 4851-4858
[Abstract]
[Full Text]
-
Singh, N., Van Kaer, L.
(1999). Unexpected Reactivities of T Cells Selected by a Single MHC-Peptide Ligand. J. Immunol.
163: 3583-3591
[Abstract]
[Full Text]
-
Gross, D. M., Forsthuber, T., Tary-Lehmann, M., Etling, C., Ito, K., Nagy, Z. A., Field, J. A., Steere, A. C., Huber, B. T.
(1998). Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis. Science
281: 703-706
[Abstract]
[Full Text]